Loading clinical trials...

Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR). | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT02210351

Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR).

The asses and evaluate whether trans apical access for TAVR is associated with apical dysfunction.

Lead sponsor: Sheba Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Danny Spiegelstein, Dr

CONTACT

972-35307339 [email protected]

Related studies

COMPLETED

Alternative Access Approaches for Transcatheter Aortic Valve Replace (TAVR) in Inoperable Patients With Aortic Stenosis

NCT01787084 · Severe Symptomatic Aortic Stenosis

COMPLETED

Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities

NCT04663334 · Severe Symptomatic Aortic Stenosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 6, 2014Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment45

Start dateSep 2014

Last updatedAug 6, 2014

Condition

Severe Symptomatic Aortic Stenosis

Locations shown

Leviev Heart Center, Sheba Medical Center

Ramat Gan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions